Article Details

After an analyst downgrade, Emergent BioSolutions (NYSE:EBS) sets a new one-year low.

Retrieved on: 2022-11-10 07:53:01

Tags for this article:

Click the tags to see associated articles and topics

After an analyst downgrade, Emergent BioSolutions (NYSE:EBS) sets a new one-year low.. View article details on HISWAI: https://beststocks.com/after-an-analyst-downgrade-emergent-biosolutions/

Excerpt

BlackRock Inc. now has 8,731,904 shares of the biopharmaceutical company's stock, which are currently valued at $358,533,000 after purchasing an ...

Article found on: beststocks.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up